Last reviewed · How we verify
TolaSure Topical Gel — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
TolaSure Topical Gel (TolaSure Topical Gel) — BioMendics, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TolaSure Topical Gel TARGET | TolaSure Topical Gel | BioMendics, LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TolaSure Topical Gel CI watch — RSS
- TolaSure Topical Gel CI watch — Atom
- TolaSure Topical Gel CI watch — JSON
- TolaSure Topical Gel alone — RSS
Cite this brief
Drug Landscape (2026). TolaSure Topical Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/tolasure-topical-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab